Related Experiment Video
Updated: Aug 9, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection
1Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Insights
Hepatitis B (HBV) and hepatitis C (HCV) coinfection causes severe liver disease and increases liver cancer risk. Treating dual HBV/HCV infections presents significant challenges for healthcare providers.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Hepatitis B virus (HBV) and hepatitis C virus (HCV) are major causes of global liver disease.
- Shared transmission routes facilitate HBV and HCV coinfection, particularly in high-prevalence areas and among those at risk for parenteral exposure.
- Dual HBV/HCV infection is associated with more severe liver pathology and a higher risk of developing hepatocellular carcinoma (HCC).
Purpose of the Study:
- To highlight the clinical significance of HBV and HCV coinfection.
- To underscore the challenges in managing patients with dual viral hepatitis infections.
- To emphasize the increased risk of severe liver disease and HCC in coinfected individuals.
Main Methods:
- This abstract is based on a review of existing literature regarding HBV and HCV infections.
- The focus is on understanding the epidemiology, clinical outcomes, and treatment challenges of coinfection.
- No new experimental data were generated; the summary synthesizes current knowledge.
Main Results:
- Coinfection with HBV and HCV leads to more aggressive liver disease compared to single infections.
- Patients with dual infections face an elevated risk of progressing to liver cancer (HCC).
- Effective treatment strategies for dual HBV/HCV infections remain a significant clinical hurdle.
Conclusions:
- HBV/HCV coinfection represents a serious public health concern due to its association with severe liver disease and HCC.
- The management of patients with both HBV and HCV infections requires specialized approaches due to treatment complexities.
- Further research and improved therapeutic options are needed to address the challenges posed by dual hepatitis virus infections.
Abstract:
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections account for a substantial proportion of liver diseases worldwide. Because the two hepatotropic viruses share same modes of transmission, coinfection with the two viruses is not uncommon, especially in areas with a high prevalence of HBV infection and among people at high risk for parenteral infection. Patients with dual HBV and HCV infection have more severe liver disease, and are at an increased risk for progression to hepatocellular carcinoma (HCC). Treatment of viral hepatitis due to dual HBV/HCV infection represents a challenge.
More Related Videos
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Viruses with RNA Genomes
Viral Recombination
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...